Showing 73–84 of 112 results

Rituxan / MabThera 100 mg Alternative – Relyto (Rituximab) 100 mg IV infusion | Incepta Pharmaceuticals

Relyto 100 mg (Rituximab) IV infusion is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Rituxan / MabThera (Roche / Genentech).

Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Rituxan / MabThera 500 mg Alternative – Relyto (Rituximab) 500 mg IV infusion | Incepta Pharmaceuticals

Relyto 500 mg (Rituximab) IV infusion is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Rituxan / MabThera (Roche / Genentech).

Pack: 1 vial. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Sprycel 100 mg Alternative – Dasanix (Dasatinib) 100 mg Tablet | Beacon Pharmaceuticals

Dasanix 100 mg (Dasatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Sprycel. BCR-ABL kinase inhibitor; used in selected Philadelphia chromosome-positive leukemias. Prescription medicine. Brand comparison does not establish interchangeability.

Sprycel 20 mg Alternative – Dasanix (Dasatinib) 20 mg Tablet | Beacon Pharmaceuticals

Dasanix 20 mg (Dasatinib) Tablet by Beacon Pharmaceuticals. Reference brand: Sprycel. BCR-ABL kinase inhibitor; used in selected Philadelphia chromosome-positive leukemias. Prescription medicine. Brand comparison does not establish interchangeability.

Stivarga 40 mg Alternative – Regocent (Regorafenib) 40 mg Tablet | Incepta Pharmaceuticals

Regocent 40 mg (Regorafenib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Stivarga (Bayer).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Stivarga 40 mg Alternative – Regora (Regorafenib) 40 mg Tablet | Beacon Pharmaceuticals

Regora 40 mg (Regorafenib) Tablet by Beacon Pharmaceuticals. Reference brand: Stivarga. multikinase inhibitor; used in selected previously treated colorectal cancer, GIST and liver cancer. Prescription medicine. Brand comparison does not establish interchangeability.

Sutent 50 mg Alternative – Sunicent (Sunitinib) 50 mg Capsule | Incepta Pharmaceuticals

Sunicent 50 mg (Sunitinib) Capsule is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Sutent (Pfizer).

Pack: 12 capsules. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Sutent 50 mg Alternative – Sunitix (Sunitinib) 50 mg Capsule | Beacon Pharmaceuticals

Sunitix 50 mg (Sunitinib) Capsule by Beacon Pharmaceuticals. Reference brand: Sutent. multikinase inhibitor; used in selected kidney cancer, GIST and pancreatic neuroendocrine tumors. Prescription medicine. Brand comparison does not establish interchangeability.

Tabrecta 200 mg Alternative – Capmaxen (Capmatinib) 200 mg Tablet | Everest Pharmaceuticals

Capmaxen 200 mg (Capmatinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Tabrecta (Novartis). It belongs to the MET inhibitor class and is used in selected MET exon 14 skipping non-small cell lung cancer.

Active ingredient: Capmatinib
Strength: 200 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Tagrisso 80 mg Alternative – Osicent (Osimertinib) 80 mg Tablet | Incepta Pharmaceuticals

Osicent 80 mg (Osimertinib) Tablet is listed in the supplied Lucent price catalogue attributed to Incepta Pharmaceuticals Ltd. Reference brand: Tagrisso (AstraZeneca).

Pack: 10 tablets. Prescription medicine. Verify the exact manufacturer label and regulatory status; reference-brand comparison does not establish interchangeability.

Tagrisso 80 mg Alternative – Osimert (Osimertinib) 80 mg Tablet | Everest Pharmaceuticals

Osimert 80 mg (Osimertinib) by Everest Pharmaceuticals Ltd. is listed as an alternative-brand option for customers researching Tagrisso (AstraZeneca). It belongs to the EGFR tyrosine kinase inhibitor class and is used in selected EGFR-mutated non-small cell lung cancer.

Active ingredient: Osimertinib
Strength: 80 mg
Form: Tablet
Manufacturer: Everest Pharmaceuticals Ltd., Bangladesh

Prescription required. Shared active ingredients do not establish bioequivalence or automatic interchangeability.

Tagrisso 80 mg Alternative – Ositag (Osimertinib) 80 mg Tablet | Beacon Pharmaceuticals

Ositag 80 mg (Osimertinib) Tablet by Beacon Pharmaceuticals. Reference brand: Tagrisso. EGFR inhibitor; used in selected EGFR-mutated lung cancer. Prescription medicine. Brand comparison does not establish interchangeability.